Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag Induced Liver Dysfunction in ITP
NCT07093606Recruiting
- Sponsor
- Sohag University
- Start
- Jul 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of eltrombopag in immune thrombocytopenia (ITP), sponsored by Sohag University. Primary endpoint: Incidence and severity of liver dysfunction. Started Jul 2025; status: recruiting.
02
Drugs
eltrombopag
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT07093606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07093606.